Cortical Thickness and Anxiety Symptoms Among Cognitively Normal Elderly Persons: The Mayo Clinic Study of Aging
Jazyk angličtina Země Spojené státy americké Médium print-electronic
Typ dokumentu časopisecké články
Grantová podpora
K01 MH068351
NIMH NIH HHS - United States
R01 AG041851
NIA NIH HHS - United States
R01 AG034676
NIA NIH HHS - United States
U01 AG024904
NIA NIH HHS - United States
R01 AG011378
NIA NIH HHS - United States
R01 AG037551
NIA NIH HHS - United States
R01 AG043392
NIA NIH HHS - United States
K01 AG028573
NIA NIH HHS - United States
U01 AG006786
NIA NIH HHS - United States
PubMed
27578447
PubMed Central
PMC5473777
DOI
10.1176/appi.neuropsych.15100378
Knihovny.cz E-zdroje
- Klíčová slova
- Biological Markers, Neuropsychology,
- MeSH
- apolipoprotein E4 genetika MeSH
- deprese diagnostické zobrazování epidemiologie MeSH
- komorbidita MeSH
- lidé MeSH
- magnetická rezonanční tomografie MeSH
- mozková kůra diagnostické zobrazování MeSH
- průřezové studie MeSH
- psychiatrické posuzovací škály MeSH
- senioři MeSH
- stárnutí patologie psychologie MeSH
- úzkost diagnostické zobrazování epidemiologie MeSH
- velikost orgánu MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- Geografické názvy
- Minnesota epidemiologie MeSH
- Názvy látek
- apolipoprotein E4 MeSH
The authors conducted a cross-sectional study to investigate the association between anxiety symptoms and cortical thickness, as well as amygdalar volume. A total of 1,505 cognitively normal participants, aged ≥70 years, were recruited from the Mayo Clinic Study of Aging in Olmsted County, Minnesota, on whom Beck Anxiety Inventory and 3T brain MRI data were available. Even though the effect sizes were small in this community-dwelling group of participants, anxiety symptoms were associated with reduced global cortical thickness and reduced thickness within the frontal and temporal cortex. However, after additionally adjusting for comorbid depressive symptoms, only the association between anxiety symptoms and reduced insular thickness remained significant.
Zobrazit více v PubMed
Grenier S, Preville M, Boyer R, et al. The impact of DSM-IV symptom and clinical significance criteria on the prevalence estimates of subthreshold and threshold anxiety in the older adult population. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry. 2011;19:316–26. PubMed PMC
Geda YE, Roberts RO, Mielke MM, et al. Baseline neuropsychiatric symptoms and the risk of incident mild cognitive impairment: a population-based study. AJ Psychiatry. 2014;171:572–81. PubMed PMC
Creed F, Morgan R, Fiddler M, Marshall S, Guthrie E, House A. Depression and anxiety impair health-related quality of life and are associated with increased costs in general medical inpatients. Psychosomatics. 2002;43:302–9. PubMed
Miloyan B, Byrne GJ, Pachana NA. Threshold and subthreshold generalized anxiety disorder in later life. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry. 2015;23:633–41. PubMed
Sperling RA, Aisen PS, Beckett LA, et al. Toward defining the preclinical stages of Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7:280–92. PubMed PMC
Singh V, Chertkow H, Lerch JP, Evans AC, Dorr AE, Kabani NJ. Spatial patterns of cortical thinning in mild cognitive impairment and Alzheimer’s disease. Brain. 2006;129:2885–93. PubMed
Grieve SM, Korgaonkar MS, Koslow SH, Gordon E, Williams LM. Widespread reductions in gray matter volume in depression. Neuroimage Clin. 2013;3:332–9. PubMed PMC
Frick A, Howner K, Fischer H, Eskildsen SF, Kristiansson M, Furmark T. Cortical thickness alterations in social anxiety disorder. Neurosci Lett. 2013;536:52–5. PubMed
Fischl B, Dale AM. Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc Natl Acad Sci USA. 2000;97:11050–5. PubMed PMC
Donzuso G, Cerasa A, Gioia MC, Caracciolo M, Quattrone A. The neuroanatomical correlates of anxiety in a healthy population: differences between the State-Trait Anxiety Inventory and the Hamilton Anxiety Rating Scale. Brain Behav. 2014;4:504–14. PubMed PMC
Hayano F, Nakamura M, Asami T, et al. Smaller amygdala is associated with anxiety in patients with panic disorder. Psychiatry Clin Neurosci. 2009;63:266–76. PubMed
Massana G, Serra-Grabulosa JM, Salgado-Pineda P, et al. Amygdalar atrophy in panic disorder patients detected by volumetric magnetic resonance imaging. Neuroimage. 2003;19:80–90. PubMed
Moon CM, Kim GW, Jeong GW. Whole-brain gray matter volume abnormalities in patients with generalized anxiety disorder: voxel-based morphometry. Neuroreport. 2014;25:184–9. PubMed
Beekman AT, de Beurs E, van Balkom AJ, Deeg DJ, van Dyck R, van Tilburg W. Anxiety and depression in later life: Co-occurrence and communality of risk factors. The American journal of psychiatry. 2000;157:89–95. PubMed
Flint AJ. Epidemiology and comorbidity of anxiety disorders in the elderly. The American journal of psychiatry. 1994;151:640–9. PubMed
Kessler RC, Birnbaum HG, Shahly V, et al. Age differences in the prevalence and co-morbidity of DSM-IV major depressive episodes: results from the WHO World Mental Health Survey Initiative. Depress Anxiety. 2010;27:351–64. PubMed PMC
Roberts RO, Geda YE, Knopman DS, et al. The Mayo Clinic Study of Aging: design and sampling, participation, baseline measures and sample characteristics. Neuroepidemiology. 2008;30:58–69. PubMed PMC
Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology. 1993;43:2412–4. PubMed
Rey A. L’examen clinique en psychologie. Presses Universitaires de France; Paris: 1964.
Wechsler D. Wechsler Memory Scale-Revised. The Psychological Corporation; New York: 1987.
Kaplan E, Goodglass H, Brand S. Boston Naming Test. Lea & Febiger; Philadelphia: 1983.
Wechsler D. Wechsler Adult Intelligence Scale-Revised. Psychological Corporation; New York: 1981.
Reitan RM. Validity of the Trail Making Test as an indicator of organic brain damage. Percept Mot Skills. 1958;8:271–276.
Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol. 1988;56:893–7. PubMed
Jack CR, Jr, Bernstein MA, Borowski BJ, et al. Update on the magnetic resonance imaging core of the Alzheimer’s disease neuroimaging initiative. Alzheimer’s & dementia : the journal of the Alzheimer’s Association. 2010;6:212–20. PubMed PMC
Jack CR, Jr, Lowe VJ, Senjem ML, et al. 11C PiB and structural MRI provide complementary information in imaging of Alzheimer’s disease and amnestic mild cognitive impairment. Brain. 2008;131:665–80. PubMed PMC
Gunter JL, Bernstein MA, Borowski BJ, et al. Measurement of MRI scanner performance with the ADNI phantom. Med Phys. 2009;36:2193–205. PubMed PMC
Fischl B, Salat DH, Busa E, et al. Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron. 2002;33:341–55. PubMed
Jack CR, Jr, Twomey CK, Zinsmeister AR, Sharbrough FW, Petersen RC, Cascino GD. Anterior temporal lobes and hippocampal formations: normative volumetric measurements from MR images in young adults. Radiology. 1989;172:549–54. PubMed
Beck AT, Steer RA, Brown GK. BDI-II, Beck Depression Inventory: Manual. Psychological Corp. Harcourt Brace; San Antonio, TX; Boston, MA: 1996.
Schoevers RA, Beekman AT, Deeg DJ, Jonker C, van Tilburg W. Comorbidity and risk-patterns of depression, generalised anxiety disorder and mixed anxiety-depression in later life: results from the AMSTEL study. Int J Geriatr Psychiatry. 2003;18:994–1001. PubMed
Kessler RC, McGonagle KA, Nelson CB, Hughes M, Swartz M, Blazer DG. Sex and depression in the National Comorbidity Survey. II: Cohort effects. J Affect Disord. 1994;30:15–26. PubMed
Geda YE, Roberts RO, Knopman DS, et al. Prevalence of neuropsychiatric symptoms in mild cognitive impairment and normal cognitive aging: population-based study. Arch Gen Psychiatry. 2008;65:1193–8. PubMed PMC
Kokmen E, Naessens JM, Offord KP. A Short Test of Mental Status: description and preliminary results. Mayo Clin Proc. 1987;62:281–8. PubMed
van Tol MJ, van der Wee NJ, van den Heuvel OA, et al. Regional brain volume in depression and anxiety disorders. Arch Gen Psychiatry. 2010;67:1002–11. PubMed
Uchida RR, Del-Ben CM, Busatto GF, et al. Regional gray matter abnormalities in panic disorder: a voxel-based morphometry study. Psychiatry Res. 2008;163:21–9. PubMed
Asami T, Hayano F, Nakamura M, et al. Anterior cingulate cortex volume reduction in patients with panic disorder. Psychiatry Clin Neurosci. 2008;62:322–30. PubMed
Yoo HK, Kim MJ, Kim SJ, et al. Putaminal gray matter volume decrease in panic disorder: an optimized voxel-based morphometry study. The European journal of neuroscience. 2005;22:2089–94. PubMed
Vythilingam M, Anderson ER, Goddard A, et al. Temporal lobe volume in panic disorder–a quantitative magnetic resonance imaging study. Psychiatry Res. 2000;99:75–82. PubMed
Singer T, Critchley HD, Preuschoff K. A common role of insula in feelings, empathy and uncertainty. Trends Cogn Sci. 2009;13:334–40. PubMed
Salat DH, Buckner RL, Snyder AZ, et al. Thinning of the cerebral cortex in aging. Cereb Cortex. 2004;14:721–30. PubMed
Freeman SH, Kandel R, Cruz L, et al. Preservation of neuronal number despite age-related cortical brain atrophy in elderly subjects without Alzheimer disease. J Neuropathol Exp Neurol. 2008;67:1205–12. PubMed PMC